Point72 Asia Singapore Pte. Ltd. Invests $439,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 14,010 shares of the company’s stock, valued at approximately $439,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC raised its position in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after purchasing an additional 4,304,896 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new position in shares of Option Care Health in the second quarter valued at approximately $68,003,000. Victory Capital Management Inc. raised its holdings in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares during the last quarter. Magnetar Financial LLC boosted its position in Option Care Health by 124.8% during the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after buying an additional 1,377,929 shares during the period. Finally, Duquesne Family Office LLC grew its holdings in Option Care Health by 172.8% during the 2nd quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after acquiring an additional 1,185,613 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Performance

OPCH stock opened at $24.12 on Tuesday. The firm has a market cap of $4.10 billion, a PE ratio of 20.27, a price-to-earnings-growth ratio of 2.46 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a 50-day moving average price of $26.84 and a 200-day moving average price of $28.87. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63.

Analyst Ratings Changes

OPCH has been the subject of several analyst reports. Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Barrington Research lowered their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Finally, JMP Securities upped their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.